Observational studyThe Lancet. Neurology2020

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.

Tanya Simuni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.